List of chapters, authors, reviewers and contributors
Updated 10 January 2023
Overall authors
-
Chris Whitty, Chief Medical Officer (CMO), England
-
Gregor Smith, CMO, Scotland
-
Frank Atherton, CMO, Wales
-
Michael McBride, CMO, Northern Ireland
-
Patrick Vallance, UK Government Chief Scientific Adviser
-
Jenny Harries, Deputy Chief Medical Officer (DCMO), England (July 2019 to April 2021), Chief Executive UK Health Security Agency (UKHSA) (2021 onwards)
-
Stephen Powis, National Medical Director, NHS England
-
Jonathan Van-Tam, DCMO, England (October 2017 to March 2022)
-
Nicola Steedman, DCMO, Scotland
-
Graham Ellis, DCMO, Scotland
-
Marion Bain, Interim DCMO, Scotland
-
Lourda Geoghegan, DCMO, Northern Ireland
-
Naresh Chada, DCMO, Northern Ireland
-
Chris Jones, DCMO, Wales
-
Aidan Fowler, DCMO, England
-
Thomas Waite, DCMO, England
Note 1: all overall authors listed above reviewed all chapters and are not re-listed as reviewers within the chapter list.
Note 2: many authors, reviewers and contributors have changed organisations during the period 2020 to 2022, or are affiliated to more than one organisation. Here we use the most relevant organisation for their role in this report.
Chapter 1: understanding the pathogen
Section 1: What was this pathogen?
Name | Organisation | Role |
---|---|---|
Anika Singanayagam | Imperial College London | Author |
Emma Thomson | Medical Research Council, University of Glasgow Centre for Virus Research | Reviewer |
Anna Jeffery-Smith | UKHSA | Contributor |
Section 2: What information could be gathered about the pathogen that could help develop an initial diagnostic test?
Name | Organisation | Role |
---|---|---|
Anika Singanayagam | Imperial College London | Author |
Jonathan Youngs | Kings College Hospital NHS Foundation Trust | Contributor |
Jo Martin | Queen Mary University of London | Reviewer |
Section 3: What information about the pathogen and the disease could support targeting of appropriate repurposed and newly developed pharmaceutical interventions?
Name | Organisation | Role |
---|---|---|
Anna Jeffery-Smith | UKHSA | Author |
Anika Singanayagam | Imperial College London | Contributor |
Emma Sherwood | UKHSA | Contributor |
Peter Horby | University of Oxford | Reviewer |
Section 4: How could viral evolution be monitored?
Name | Organisation | Role |
---|---|---|
Thomas Peacock | Imperial College London | Author |
Wendy Barclay | Imperial College London | Author |
Section 5: How severe was this disease, and were there longer-term sequelae?
Name | Organisation | Role |
---|---|---|
Tom Evans | University of Glasgow | Author |
Catherine Huntley | Royal Free Hospital NHS Foundation Trust | Contributor |
John Edmunds | London School of Hygiene and Tropical Medicine | Reviewer |
Section 6: What was the duration of naturally acquired and vaccine acquired immunity, and the risk of reinfection over time?
Name | Organisation | Role |
---|---|---|
Catherine Huntley | Royal Free Hospital NHS Foundation Trust | Author |
Susan Hopkins | UKHSA | Reviewer |
Peter Horby | University of Oxford | Reviewer |
Anna Jeffery-Smith | UKHSA | Contributor |
Section 7: What were the case definitions?
Name | Organisation | Role |
---|---|---|
Catherine Huntley | Royal Free Hospital NHS Foundation Trust | Author |
Anna Jeffery-Smith | UKHSA | Contributor |
Andrew Hayward | UCL | Reviewer |
Susan Hopkins | UKHSA | Reviewer |
Peter Horby | University of Oxford | Reviewer |
Section 8: What were the important routes of transmission?
Name | Organisation | Role |
---|---|---|
Harry Rutter | University of Bath | Author |
Manuj Sharma | Royal Free Hospital NHS Foundation Trust | Author |
Catherine Noakes | University of Leeds | Reviewer |
Andrew Hayward | University College of London | Reviewer |
Section 9: What were the higher risk settings for transmission?
Name | Organisation | Role |
---|---|---|
Harry Rutter | University of Bath | Author |
Manuj Sharma | Royal Free Hospital NHS Foundation Trust | Author |
Catherine Noakes | University of Leeds | Reviewer |
Andrew Hayward | University College of London | Reviewer |
Section 10: What was the proportion of asymptomatic infection and transmission, and could this maintain R over 1?
Name | Organisation | Role |
---|---|---|
Catherine Huntley | Royal Free Hospital NHS Foundation Trust | Author |
Anika Singanayagam | Imperial College London | Contributor |
Peter Horby | University of Oxford | Reviewer |
Section 11: How long were people infectious?
Name | Organisation | Role |
---|---|---|
Catherine Huntley | Royal Free Hospital NHS Foundation Trust | Author |
Anika Singanayagam | Imperial College London | Contributor |
Emer O’Connell | UKHSA | Contributor |
Peter Horby | University of Oxford | Reviewer |
Chapter 2: disparities
Name | Organisation | Role |
---|---|---|
Catherine Falconer | UKHSA | Author |
Meaghan Kall | UKHSA | Author |
Adam Briggs | UKHSA | Author |
Ines Campos-Matos | UKHSA | Author |
Jeanelle de Gruchy | DHSC | Reviewer |
Kevin Fenton | DHSC | Reviewer |
Kamlesh Khunti | Leicester University | Reviewer |
Yvonne Doyle | NHS England | Reviewer |
Chapter 3: research
Jointly authored by UK CMOs and GCSA.
Chapter 4: situational awareness, analysis and assessment
Name | Organisation | Role |
---|---|---|
Anna Seale | UKHSA | Author |
Matthew Sexton | UKHSA | Author |
Tom Ward | UKHSA | Author |
Clare Griffiths | UKHSA | Contributor |
Alex Tibbs | DHSC | Contributor |
Alyson O’Neill | UKHSA | Contributor |
James Gilbert | UKHSA | Contributor |
Steffan Jones | Cabinet Office | Contributor |
Fergus Cumming | UKHSA | Reviewer |
Jo Trott | Welsh Government | Reviewer |
Paul Cleary | UKHSA | Reviewer |
Alex Wilson | Cabinet Office | Reviewer |
Brendan Collins | Welsh Government | Reviewer |
Andre Charlett | UKHSA | Reviewer |
Martin Burns | UKHSA | Reviewer |
Monika Preuss | UKHSA | Reviewer |
Graeme Childe | UKHSA | Reviewer |
Elizabeth Richards | DHSC | Reviewer |
Chapter 5: modelling
Name | Organisation | Role |
---|---|---|
Elizabeth Richards | DHSC | Author |
Tom Irving | DHSC | Author |
Graham Medley | London School of Hygiene and Tropical Medicine | Reviewer |
Brendan Collins | Welsh Government | Reviewer |
Rob Orford | Welsh Government | Reviewer |
Ian Young | Chief Scientific Adviser, Department of Health, Northern Ireland | Reviewer |
Chapter 6: testing
Name | Organisation | Role |
---|---|---|
Sue Hill | NHS England | Author |
Jo Martin | Queen Mary University of London | Author |
Tom Fowler | UKHSA | Author |
Polly Ashmore | Royal Free Hospital NHS Foundation Trust | Author |
Jo-Anne Daniels | Welsh Government | Contributor |
Sioned Rees | Welsh Government | Contributor |
Emily Warren-Barratt | NHS England | Contributor |
Maria Zambon | UKHSA | Contributor |
Kathleen Keary | UKHSA | Contributor |
Anna Summerhayes | UKHSA | Contributor |
Yvonne Doyle | NHS England | Reviewer |
Niamh O’Connor | Scottish Government | Reviewer |
Jeanelle de Gruchy | DHSC | Reviewer |
Isabel Oliver | UKHSA | Reviewer (genomics section) |
Saheer Gharbia | UKHSA | Reviewer (genomics section) |
Chapter 7: contact tracing and isolation
Name | Organisation | Role |
---|---|---|
Petra Manley | UKHSA | Author |
Obaghe Edeghere | UKHSA | Author |
Polly Ashmore | Royal Free Hospital NHS Foundation Trust | Author |
Nia Roberts | Welsh Government | Author |
Joanne McClean | Public Health Agency, Northern Ireland | Author |
Kieran McAteer | Department of Health, Northern Ireland | Author |
Michael Deery | Department of Health, Northern Ireland | Author |
Colin Sumpter | Public Health Scotland | Author |
Jeanelle de Gruchy | DHSC | Reviewer |
Yvonne Doyle | NHS England | Reviewer |
Isabel Oliver | UKHSA | Reviewer |
Chapter 8: non-pharmaceutical interventions
Name | Organisation | Role |
---|---|---|
Polly Ashmore | Royal Free Hospital NHS Foundation Trust | Author |
Emer O’Connell | UKHSA | Contributor |
Richard Amlot | UKHSA | Contributor |
Luke Hounsome | UKHSA | Contributor (evidence review) |
Tim Laurence | UKHSA | Contributor (evidence review) |
Daniel Herr | UKHSA | Contributor (evidence review) |
Galena Kuyumdzhieva | UKHSA | Contributor (evidence review) |
Deborah Shackleton | UKHSA | Contributor (evidence review) |
Evija Dzene | UKHSA | Contributor (evidence review) |
Sodiq Rafiu | UKHSA | Contributor (evidence review) |
Nisha Mehta | UKHSA | Contributor (shielding) |
Katherine Goodwin | Scottish Government | Contributor (shielding) |
Jeanelle de Gruchy | DHSC | Reviewer |
Renu Bindra | UKHSA | Reviewer |
Daphne Duval | UKHSA | Reviewer |
Fergus Cumming | UKHSA | Reviewer |
Calum Semple | University of Liverpool | Reviewer (shielding) |
Jonathan Benger | NHS Digital | Reviewer (shielding) |
Shamim Rahman | DHSC | Reviewer (shielding) |
Chapter 8.1: NPIs in education settings
Name | Organisation | Role |
---|---|---|
Catherine Falconer | UKHSA | Author |
Diane Stockton | Public Health Scotland | Contributor |
Colin Sumpter | Public Health Scotland | Contributor |
Joanne McClean | Department of Health, Northern Ireland | Contributor |
Heather Payne | Welsh Government | Contributor |
Fiona Henderson | UKHSA | Contributor |
Charlotte Smith | UKHSA | Contributor |
Jeanelle de Gruchy | DHSC | Reviewer |
Chapter 8.2: care homes
Name | Organisation | Role |
---|---|---|
Jackie Cassell | UKHSA | Author |
Martyn Regan | UKHSA | Author |
Éamonn O’Moore | UKHSA | Author |
Steve Willner | UKHSA | Contributor |
Rita Huyton | UKHSA | Contributor |
Melissa McMahon | UKHSA | Contributor |
Shona Arora | UKHSA | Reviewer |
John Watkins | Public Health Wales / Cardiff University | Reviewer |
Jeanelle de Gruchy | DHSC | Reviewer |
Chapter 9: pharmaceutical interventions: therapeutics and vaccines
Name | Organisation | Role |
---|---|---|
Emma Sherwood | UKHSA | Author |
Luke Collet-Fenson | DHSC | Author |
Jonathan Van-Tam | DHSC | Reviewer |
Chapter 10: improvements in care of COVID-19
Name | Organisation | Role |
---|---|---|
Polly Ashmore | Royal Free Hospital NHS Foundation Trust | Author |
Emma Sherwood | UKHSA | Author |
Tim Cook | Royal United Hospitals Bath NHS Foundation Trust | Reviewer (clinical care and health system sections) |
Susan Hopkins | UKHSA | Reviewer |
Prof Mark Wilcox | NHS England | Reviewer (infection prevention and control (IPC) section) |
Dr Lisa Ritchie | NHS England | Reviewer (IPC section) |
John Scott | NHS England | Reviewer (IPC section) |
Elaine Ross | Scottish Government | Reviewer (IPC section) |
Laura Imrie | Antimicrobial Resistance and Healthcare Associated Infection Scotland | Reviewer (IPC section) |
Chapter 11: communications
Name | Organisation | Role |
---|---|---|
Marc Masey | DHSC | Author |